with a Cardinal Health representative
Thank you for connecting with us.
Please fill out this field

How do community oncologists view biosimilars?

Research findings show that while oncologists are familiar with biosimilars and comfortable prescribing for both cure and disease control, concerns remain about the overall FDA approval process and the use of extrapolation.

Download the infographic